Congress sets sights on pharma legislation
A bipartisan group of lawmakers introduced a bundle of bills on Thursday designed to empower the Federal Trade Commission to stop branded pharmaceutical companies from delaying market entry of generic competition.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10